Cargando…

Using Multivalent Adenoviral Vectors for HIV Vaccination

Adenoviral vectors have been used for a variety of vaccine applications including cancer and infectious diseases. Traditionally, Ad-based vaccines are designed to express antigens through transgene expression of a given antigen. For effective vaccine development it is often necessary to express or p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Linlin, Li, Zan C., Krendelchtchikov, Alexandre, Krendelchtchikova, Valentina, Wu, Hongju, Matthews, Qiana L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610663/ https://www.ncbi.nlm.nih.gov/pubmed/23555957 http://dx.doi.org/10.1371/journal.pone.0060347

Ejemplares similares

Multivalent adenoviral vectors which use an antigen capsid-incorporation strategy for HIV vaccination
por: Gu, L, et al.
Publicado: (2012)

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the “Antigen Capsid-Incorporation” strategy
por: Gu, Linlin, et al.
Publicado: (2014)

Development of an Ad5H3 Chimera Using the “Antigen Capsid-Incorporation” Strategy for an Alternative Vaccination Approach
por: Gu, Linlin, et al.
Publicado: (2016)

Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection
por: Farrow, Anitra L., et al.
Publicado: (2014)

A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors
por: Farrow, Anitra L., et al.
Publicado: (2016)

Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)

Differential binding of the HIV-1 envelope to phosphatidylserine receptors
por: Gu, Linlin, et al.
Publicado: (2017)

Neural stem cell-derived exosomes mediate viral entry
por: Sims, Brian, et al.
Publicado: (2014)

Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells
por: Sims, Brian, et al.
Publicado: (2017)

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
por: Afkhami, Sam, et al.
Publicado: (2023)

Tetraspanin blockage reduces exosome-mediated HIV-1 entry
por: Sims, Brian, et al.
Publicado: (2018)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Epitope Capsid-Incorporation: A New Effective Approach for Vaccine Development for Chagas Disease
por: Matthews, Qiana L., et al.
Publicado: (2016)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

The use of adenoviral vectors in gene therapy and vaccine approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022)

An Adenoviral Vector Based Vaccine for Rhodococcus equi
por: Giles, Carla, et al.
Publicado: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates
por: Takahashi, Marie-Noëlle, et al.
Publicado: (2010)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
por: Abbink, Peter, et al.
Publicado: (2018)

Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
por: Kerstetter, Lucas J., et al.
Publicado: (2021)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
por: Kis, Zoltán, et al.
Publicado: (2022)

Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
por: Farhad, Tasneem, et al.
Publicado: (2022)

Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines
por: Borovjagin, Anton V., et al.
Publicado: (2014)

Current progress in the development of a prophylactic vaccine for HIV-1
por: Gamble, Lena J, et al.
Publicado: (2010)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
por: Padron-Regalado, Eriko, et al.
Publicado: (2022)

Updates and New Perspectives on Adenoviral Gene Therapy and Vaccine Vectors
por: Dobner, Thomas, et al.
Publicado: (2023)

An adenoviral vector-based mucosal vaccine is effective in protection against botulism
por: Xu, Q, et al.
Publicado: (2009)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

The Role of Chromatin in Adenoviral Vector Function
por: Wong, Carmen M., et al.
Publicado: (2013)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Coughlan, Lynda
Publicado: (2020)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Mendonça, Samir Andrade, et al.
Publicado: (2021)

Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination
por: Roncati, Luca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6trqqr2ar3o8dcngbgv5vh07q1